Trial Profile
FK199B (Zolpidem MR Tablet) Phase III Clinical Study - A Double-Blind, Crossover, Comparative Polysomnographic Study Using Zolpidem (Myslee) as a Positive Control in Patients With Insomnia, Excluding Patients With Schizophrenia or Manic-Depressive Psychosis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Oct 2014
Price :
$35
*
At a glance
- Drugs Zolpidem (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 31 Oct 2009 New trial record